Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05968833
Other study ID # 1000080780
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2023
Est. completion date July 1, 2025

Study information

Verified date January 2024
Source The Hospital for Sick Children
Contact Samantha J. Anthony, PhD, MSW
Phone 416-813-7654
Email samantha.anthony@sickkids.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The iParent2Parent (iP2P) program is a new, innovative virtual mentorship program that will connect parents one-to-one with other parents of pediatric kidney transplant recipients who are trained to offer vital peer support and mentorship. Parents of children who received a kidney transplant at The Hospital for Sick Children will be invited to participate as mentors and mentees (randomized into the iP2P or control group). The iP2P program can decrease feelings of isolation, improve mental health and have a long-term positive impact on patient health. This research will increase our understanding of one-to-one peer support and leverage eHealth technologies to improve the access to and acceptability of parent peer support interventions.


Recruitment information / eligibility

Status Recruiting
Enrollment 55
Est. completion date July 1, 2025
Est. primary completion date July 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Mentee Inclusion Criteria: - Parent of a patient under 18 years of age who received a kidney transplant and is at least two months post-transplant, - Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and - English-speaking. Mentor Inclusion Criteria: - Parent of a patient under 21 years of age who received a kidney transplant and is at least one year post-transplant, - Nominated by their child's healthcare team as a good candidate to act in the mentor role (e.g., good communication skills, positive adaptation and adjustment post-transplant, strong support network), - Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and - English-speaking. Exclusion Criteria: - Non-English speaking.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
iParent2Parent Program
iParent2Parent is an online peer support mentorship program that is based on the iPeer2Peer online peer support mentorship program, which has been established in multiple chronic disease populations as a self-management intervention, including in chronic pain and juvenile idiopathic arthritis populations. The iParent2Parent program connect parents one-to-one with other parents of pediatric kidney transplant recipients who are trained to offer vital peer support and mentorship.

Locations

Country Name City State
Canada The Hospital for Sick Children Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
The Hospital for Sick Children

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment rates and withdrawal rates How many participants were recruited and have withdrawn from the program on average. Baseline to study completion, an average of 1 year
Primary Adherence with the iParent2Parent program When the participant completes 10 audio or video calls over 12 weeks and 100% when all online outcome measures completed. Baseline to study completion, an average of 1 year
Primary Acceptability (Mentees) Whether the innovation is agreeable, palatable or satisfactory.
Measured via semi-structured interview or focus group.
Baseline to 12 weeks after baseline/immediately after the intervention
Primary Acceptability (Mentors) Whether the innovation is agreeable, palatable or satisfactory.
Measured via semi-structured interview or focus group.
Baseline to program completion, an average of one year
Primary Level of engagement with the iParent2Parent program (Mentees) Measured via semi-structured interview or focus group. Baseline to 12 weeks after baseline/immediately after the intervention
Primary Level of engagement with the iParent2Parent program (Mentors) Measured via semi-structured interview or focus group. Baseline to program completion, an average of one year
Primary Barriers and enablers of the iParent2Parent program (Mentees) Measured via semi-structured interview or focus group. Baseline to 12 weeks after baseline/immediately after the intervention
Primary Barriers and enablers of the iParent2Parent program (Mentors) Measured via semi-structured interview or focus group. Baseline to program completion, an average of one year
Secondary Parenting stress (Mentees and Mentors) Parental Stress Scale; 18-item questionnaire. Each question is scored on a scale from 1 to 5, with scores ranging from 18 to 90. An overall higher score means a worse outcome. Baseline to program completion, an average of one year
Secondary Psychological distress (Mentees and Mentors) General Anxiety Disorder-7; 7-item questionnaire. Each question is scored on a scale from 0 to 3, with scores ranging from 0 to 21. An overall higher score means a worse outcome. Baseline to program completion, an average of one year
Secondary Psychological distress (Mentees and Mentors) Patient Health Questionnaire Depression Scale; 8-item questionnaire. Each question is scored on a scale from 0 to 3, with scores ranging from 0 to 24. An overall higher score means a worse outcome. Baseline to program completion, an average of one year
Secondary Perceived social support (Mentees and Mentors) Short form version 2.0 of the PROMIS battery for: Social Isolation; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a worse outcome. Baseline to program completion, an average of one year
Secondary Perceived social support (Mentees and Mentors) Short form version 2.0 of the PROMIS battery for: Informational Support; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a better outcome. Baseline to program completion, an average of one year
Secondary Perceived social support (Mentees and Mentors) Short form version 2.0 of the PROMIS battery for: Emotional Support; 6-item questionnaire. Each question is scored on a scale from 1 to 5 and generates a T-score. An overall higher score means a better outcome. Baseline to program completion, an average of one year
Secondary Coping (Mentees and Mentors) Coping Health Inventory for Parents; 16-item questionnaire. Each question about coping behaviour is scored on a scale from 0 to 3, with a possible response of "Did not use" the coping behaviour. Scores range from 0 to 48. An overall higher score means a better outcome. Baseline to program completion, an average of one year
Secondary Family Functioning (Mentees and Mentors) Pediatric Quality of Life Inventory(TM) 2.0 Family Impact Module; 36-item questionnaire with 8 different sections: Physical Functioning, Emotional Functioning, Social Functioning, Cognitive Functioning, Communication, Worry, Daily Activities, and Family Relationships. Each question is scored on a scale from 0 to 4. Items are reverse-scored and linearly transformed to a 0-100 scale. An overall higher score means a better outcome. Baseline to program completion, an average of one year
See also
  Status Clinical Trial Phase
Completed NCT04087720 - Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant Phase 4
Completed NCT03749356 - Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients Phase 4
Withdrawn NCT05811468 - Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kidney Transplant Recipients
Completed NCT03527238 - Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine Phase 2
Completed NCT00498576 - Melatonin and Adiponectin in Hypertensive Kidney Transplant N/A
Completed NCT00642655 - Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation Phase 1/Phase 2
Completed NCT00374400 - The Paired Donation Consortium Paired Donation Program N/A
Completed NCT01710033 - A Study Of CP-690,550 In Stable Kidney Transplant Patients Phase 1
Completed NCT00205257 - Prediction of Acute Rejection in Renal Transplant Phase 1
Completed NCT02711826 - Treg Therapy in Subclinical Inflammation in Kidney Transplantation Phase 1/Phase 2
Withdrawn NCT03978494 - Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients. Phase 1
Completed NCT03837522 - Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies N/A
Not yet recruiting NCT06025240 - Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Completed NCT05029310 - Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients Phase 4
Completed NCT03644485 - Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients Phase 4
Active, not recruiting NCT02409901 - Effects of Personalized Physical Rehabilitation in Kidney Transplant Recipients N/A
Completed NCT01047410 - ACtive Care After Transplantation, the ACT Study N/A
Completed NCT00940940 - Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation Phase 4
Completed NCT00217126 - The Study of Long-term Deterioration of Kidney Transplants. Phase 4
Completed NCT00270712 - A Study of Factors That Affect Long-Term Kidney Transplant Function